Tag: CheckMate -743 study

FDA approves BMS’ Opdivo, Yervoy combo for malignant pleural mesothelioma

pharmanewsdaily- October 4, 2020

Bristol Myers Squibb (BMS) has secured approval for Opdivo (nivolumab) and Yervoy (ipilimumab) combination from the US Food and Drug Administration (FDA) for the first-line ... Read More